Role of Nijmegen Breakage Syndrome Protein in Specific T-Lymphocyte Activation Pathways

Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and Diagnostic Laboratory Immunology 2001-07, Vol.8 (4), p.757-761
Hauptverfasser:	Miguel Angel Garcı́a-Pérez, Luis M. Allende, Alfredo Corell, Estela Paz-Artal, Pilar Varela, Alberto López-Goyanes, Francisco Garcı́a-Martin, Rosario Vázquez, Amalia Sotoca, Antonio Arnaiz-Villena
Format:	Artikel
Sprache:	eng
Schlagworte:	B-Lymphocytes - immunology CD3 antigen CD4 antigen CD4-Positive T-Lymphocytes - drug effects CD4-Positive T-Lymphocytes - immunology CD8-Positive T-Lymphocytes - drug effects CD8-Positive T-Lymphocytes - immunology Cell Cycle Proteins - genetics Cell Cycle Proteins - immunology Child Chromosome Breakage - immunology Humans Immune-Mediated Responses and Disorders Karyotyping Lectins - metabolism Lymphocyte Activation - immunology Male Mitogens - pharmacology Mutation Nijmegen breakage syndrome protein Nuclear Proteins Syndrome T-Lymphocytes - drug effects T-Lymphocytes - immunology Tetradecanoylphorbol Acetate - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!